Article
MicroRNA-18a Improves Human Cerebral Arteriovenous Malformation Endothelial Cell Function
8 Nov 2013
Abstract excerpt
BACKGROUND AND PURPOSE: Cerebral arteriovenous malformation (AVM) is a vascular disease that disrupts normal blood flow and leads to serious neurological impairment or death. Aberrant functions of AVM-derived brain endothelial cells (AVM-BECs) are a disease hallmark. Our aim was to use microRNA-18a (miR-18a) as a therapeutic agent to improve AVM-BEC function. METHODS: Human AVM-BECs were tested for growth factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
